Track topics on Twitter Track topics that are important to you
Invitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The Asia Pacific IVF services market, valued at $3.0 billion in 2015, is estimated to reach $7.1 billion by 2022. Delayed pregnancy in women is one of the major driving factors of the embryo transfer market, as the chances of conceiving lowers with age. Success rate of getting pregnant with embryo transfer technique reduces with increase in age. Other driving factors of the embryo transfer market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. Globally, around 15% of the couples faces infertility issues in which males contribute to 2030% of the overall cases.nnThe major limiting factors of this market are the cost involved and lower success rates in the treatment. Patients may not conceive in the first cycle of embryo transfer procedure. Patients have to undergo many cycles to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $3,000 $8,000. This acts as a major limitation, in adoption of the technique, for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria, India, Indonesia among others. Awareness can be created through medical tourism and availability of low cost embryo transfer treatments. The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Fisher Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ovascience Inc.nnKEY BENEFITS FOR STAKEHOLDERS:nnnnThis report provides an indepth analysis of the AsiaPacific IVF market across twelve major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.nnThe report includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the AsiaPacific IVF market.nnThis report comprehensively analyzes the market scenario across different countries in the AsiaPacific region.nnThe projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2015 to 2022.nnExtensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.nnnKEY MARKET SEGMENTS:nnBy End Users Value and VolumennnnFertility ClinicsnnHospitalsnnSurgical CentersnnClinical Research InstitutesnnnBy Cycle Type, Value and VolumennnnFresh Cycle NonDonornnThawed IVF Cycle NonDonornnDonor Egg IVF CyclesnnnBy Cycle Type Country Level Analysis Value and VolumennnnIndiannChinannJapannnAustraliannNew ZealandnnKoreannThailandnnSingaporennMalaysiannIndonesiannPhilippinesnnVietnamnnRest of AsiaPacificn
Original Article: AsiaPacific InVitro Fertilization IVF Services Market by Cycle Type Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles and End Users Fertility Clinics, Hospitals, Surgical Centres, and Clinical Research Institutes Opportunity Analysis and Industry FNEXT ARTICLE
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...
Fertility is the ability of a couple to conceive, but can related to specifically the man or woman. Various reasons can cause a couple to be infertile, and due to the strong desire of these patients to have <!--LGfEGNT2Lhm-->children, a range of ...